PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsklebsiella infections
MeSH D007710 - klebsiella infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D004756:Enterobacteriaceae infections
38 Companies
7 Drugs
$
Success rate
D007710: 
Klebsiella infections
165 Companies
75 Drugs
$
Success rate
D012226:Rhinoscleroma
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaCeftriaxone Ceftriaxone  2007-03-15   
Ciprofloxacin Ciprofloxacin  2004-06-09   
Sulfamethoxazole, Trimethoprim Cotrim  1985-05-16   
Sulfamethoxazole, Trimethoprim Cotrim D.s  1985-03-18   
Gentamicin Gentamicin  1991-11-21   
Sulfamethoxazole, Trimethoprim Sulfamethoxazole Trimethoprim  1991-10-31   
Trimethoprim Trimethoprim  1987-06-18   
PadagisBacitracin, Polymyxin b Bacitracin Polymyxin B  2002-02-27   
Hydrocortisone, Bacitracin, Neomycin, Polymyxin b Bacitracin-neomycin-polymyxin W/ Hydrocortisone  1982-01-01   
Gentamicin Gentamicin  1982-01-01   
Bacitracin, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Bacitracin  1982-01-01   
Dexamethasone, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Dexamethasone  1989-07-31   
Taro PharmaceuticalCiprofloxacin Ciprofloxacin  2004-10-06   
Gentamicin Gentamicin  1983-05-26   
Glenmark PharmaceuticalsSulfamethoxazole, Trimethoprim Sulfamethoxazole Trimethoprim  2010-12-22   
MylanSulfamethoxazole, Trimethoprim Sulfamethoxazole Trimethoprim  2017-08-30   
NATCO PharmaCiprofloxacin Ciprofloxacin  2004-06-09   
GSKPolymyxin b Aerosporin  1982-01-01   
Ceftazidime Ceptaz  1990-09-27   
Neomycin, Polymyxin b Neosporin  1985-01-14   
Ceftazidime Pentacef  1995-11-07   
Bacitracin, Polymyxin b Polysporin  1985-03-01   
RocheCeftriaxone, Lidocaine Rocephin  1985-03-12 $261.442 M Y2021 
Trimethoprim Trimpex  1982-01-01   
1
2
3
4
5
6
...
17
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
100%
2/2
Phase 3
98%
62/63
Approved: 61Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Cefadroxil,
Cefdinir,
Cefprozil,
Moxifloxacin
Mylan
Moxifloxacin
Johnson & Johnson
Levofloxacin,
Ofloxacin
GSK
Ceftazidime,
Cefuroxime axetil,
Ampicillin,
Neomycin,
As03,
Diluent
Roche
Ceftriaxone,
Lidocaine,
Trimethoprim
Sandoz
Cefdinir,
Cefprozil
AbbVie
Avibactam,
Ceftazidime
1
2
3
4
5
6
...
11
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use